Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ketie Saralidze is active.

Publication


Featured researches published by Ketie Saralidze.


Materials | 2010

Polymeric Microspheres for Medical Applications

Ketie Saralidze; Leo H. Koole; Menno L. W. Knetsch

Synthetic polymeric microspheres find application in a wide range of medical applications. Among other applications, microspheres are being used as bulking agents, embolic- or drug-delivery particles. The exact composition of the spheres varies with the application and therefore a large array of materials has been used to produce microspheres. In this review, the relation between microsphere synthesis and application is discussed for a number of microspheres that are used for different treatment strategies.


Biomaterials | 2011

A highly radiopaque vertebroplasty cement using tetraiodinated o-carborane additive

Ariadna Pepiol; Francesc Teixidor; Ketie Saralidze; Cees van der Marel; Paul Willems; L. Voss; Menno L. W. Knetsch; Clara Viñas; Leo H. Koole

Bone cements for vertebroplasty must have a much better radiocontrast level than cements for knee or hip arthroplasty. This is generally accomplished by adding a relatively large portion of BaSO(4), although this affects the physical-mechanical and biological properties of the cement. This prompted us to develop an alternative radiopaque cement, on the basis of unique highly radiopaque methacrylic microspheres. These contain iodine in two modalities: (i) covalently linked to the methacrylic polymer, and (ii) as constituent of the stable tetraiodocarborane 8,9,10,12-I(4)-1,2-closo-C(2)B(10)H(8). The total iodine content in these particles exceeded 30% by mass. These radiopaque microspheres as well as the cement made thereof were characterized extensively, e.g., by scanning electron microscopy, X-ray contrast measurements, X-ray photoelectron spectroscopy, measurements of compressive strength, infrared spectroscopy, and solid state (11)B{(1)H} NMR spectroscopy. Furthermore, the new cement was subjected to several biocompatibility tests in vitro. The results show that the new bone cement fulfills all physico-chemical criteria for use in vertebroplasty. Further data on the cements biocompatibility (in vitro), as well as on the handling parameters and doughviscosity, indicate that this material has a potential to become an alternative to vertebroplasty cements with a high BaSO(4) content. The new cement provides two significant advantages: (i) controlled viscosity in the dough phase, which facilitates precise injection during the vertebroplasty procedure; (ii) excellent structural stability, which precludes leaching of contrast post-implantation.


Journal of Biomedical Materials Research Part B | 2012

Design, synthesis, imaging, and biomechanics of a softness-gradient hydrogel nucleus pulposus prosthesis in a canine lumbar spine model

Hendrik-Jan C. Kranenburg; Björn P. Meij; David Onis; Albert J. van der Veen; Ketie Saralidze; Luc A. Smolders; Julie G. Huizinga; Menno L. W. Knetsch; Peter R. Luijten; Fredy Visser; George Voorhout; Wouter J.A. Dhert; H.A.W. Hazewinkel; Leo H. Koole

A hydrogel nucleus pulposus prosthesis (NPP) was designed to swell in situ, have intrinsic radiopacity, and restore intervertebral disc height and biomechanical functionality. These features were examined using an ex vivo canine lumbar model. Nine NPPs were implanted in five spines and their visibility was assessed on radiography, computed tomography (CT), and magnetic resonance imaging (MRI). The NPPs were visible on all imaging modalities and 8/9 NPPs stayed intact and in situ. Six other NPPs were tested biomechanically in six canine lumbar spines. Removal of the nucleus pulposus (nuclectomy) caused significant changes in biomechanical parameters. After implantation and swelling of the NPP, values were not significantly different from the native state for range of motion (ROM) of flexion-extension (FE) and lateral bending (LB), the neutral zone (NZ) of all motion directions, and the NZ stiffness (NZS) of FE. Biomechanical restoration by the NPP compared with the nuclectomized state was significant for the ROM of FE and axial rotation, the NZ of FE and LB, and the NZS of FE and LB. Disc height was significantly restored and 6/6 NPPs stayed intact and in situ. In conclusion, the NPPs swell in situ, have intrinsic radiopacity and restored disc height and aforementioned biomechanical properties.


Biomaterials | 2016

Synthesis and characterization of a new vertebroplasty cement based on gold-containing PMMA microspheres

Eva Jacobs; Ketie Saralidze; Alex K. Roth; Joost J. A. de Jong; Joop P. W. van den Bergh; Arno Lataster; Boudewijn Brans; Menno L. W. Knetsch; Ivan Djordjevic; Paul C. Willems; Leo H. Koole

There are a number of drawbacks to incorporating large concentrations of barium sulfate (BaSO4) as the radiopacifier in PMMA-based bone cements for percutaneous vertebroplasty. These include adverse effects on injectability, viscosity profile, setting time, mechanical properties of the cement and bone resorption. We have synthesized a novel cement that is designed to address some of these drawbacks. Its powder includes PMMA microspheres in which gold particles are embedded and its monomer is the same as that used in commercial cements for vertebroplasty. In comparison to one such commercial cement brand, VertaPlex™, the new cement has longer doughing time, longer injection time, higher compressive strength, higher compressive modulus, and is superior in terms of cytotoxicity. For augmentation of fractured fresh-frozen cadaveric vertebral bodies (T6-L5) using simulated vertebroplasty, results for compressive strength and compressive stiffness of the construct and the percentage of the volume of the vertebral body filled by the cement were comparable for the two cements although the radiopacity of the new cement was significantly lower than that for VertaPlex™. The present results indicate that the new cement warrants further study.


Macromolecules | 2018

Effect of Self-Assembly of Oxalamide Based Organic Compounds on Melt Behavior, Nucleation, and Crystallization of Isotactic Polypropylene

Carolus H. R. M. Wilsens; Laurence G. D. Hawke; Em Enrico Troisi; Daniel Hermida-Merino; Gijs de Kort; Nils Leone; Ketie Saralidze; Gerrit W. M. Peters; Sanjay Rastogi

We report on the effect of an aliphatic oxalamide based nucleating agent (OXA3,6) on the melt and crystallization behavior of isotactic polypropylene (iPP) under defined shear conditions. Through polarized optical microscopy, we demonstrate that OXA3,6 self-assembles from the iPP melt into rhombic crystals whereas their size and distribution proved highly dependent on the employed cooling rates. The presence of 0.5 wt % of OXA3,6 in iPP results in a significant suppression in iPP melt viscosity, which could not be explained via molecular modeling. A possible cause for the drop in viscosity in the presence of OXA3,6 is attributed to the interaction (absorption) of high molecular weight iPP chains with the nucleating agent, thereby suppressing their contribution to the viscoelastic response of the melt. This proposed mechanism for the suppression in melt viscosity appears similar to that encountered by the homogeneous distribution of nanoparticles such as CNTs, graphene, and silica. Shear experiments, performed using a slit flow device combined with small-angle X-ray diffraction measurements, indicate that crystallization is significantly enhanced in the presence of OXA3,6 at relatively low shear rates despite its lowered sensitivity to shear. This enhancement in crystallization is attributed to the shear alignment of the rhombic OXA3,6 crystals that provide surface for iPP kebab growth upon cooling. Overall, the suppression in melt viscosity in combination with enhanced nucleation efficiency at low as well as high shear rates makes this self-assembling oxalamide based nucleating agent a promising candidate for fast processing.


Biomaterials | 2007

New acrylic microspheres for arterial embolization: combining radiopacity for precise localization with immobilized thrombin to trigger local blood coagulation.

Ketie Saralidze; Catharina S. J. van Hooy-Corstjens; Leo H. Koole; Menno L. W. Knetsch


Biomacromolecules | 2003

Injectable polymeric microspheres with X-ray visibility. Preparation, properties, and potential utility as new traceable bulking agents.

Ketie Saralidze; Yvette B.J. Aldenhoff; Menno L. W. Knetsch; Leo H. Koole


Biomacromolecules | 2008

New Intrinsically Radiopaque Hydrophilic Microspheres for Embolization : Synthesis and Characterization

Csj Tosca van Hooy-Corstjens; Ketie Saralidze; Mlw Menno Knetsch; Pj Pieter Emans; Mw Michiel de Haan; Pcmm Pieter Magusin; Brahim Mezari; Lh Leo Koole


Journal of Biomedical Materials Research Part A | 2005

Development of new injectable bulking agents: Biocompatibility of radiopaque polymeric microspheres studied in a mouse model

Pieter J. Emans; Ketie Saralidze; Menno L. W. Knetsch; Marion J. J. Gijbels; Roel Kuijer; Leo H. Koole


Biomaterials | 2010

The performance of a hydrogel nucleus pulposus prosthesis in an ex vivo canine model

Niklas Bergknut; Lucas A. Smolders; Leo H. Koole; George Voorhout; Ragnvi Hagman; Anne-Sofie Lagerstedt; Ketie Saralidze; H.A.W. Hazewinkel; Albert J. van der Veen; Björn P. Meij

Collaboration


Dive into the Ketie Saralidze's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alex K. Roth

Maastricht University Medical Centre

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge